Silver Book Fact

A new study reports that using optogenetics, stimulating specific brain cells using light, may provide better results for Parkinson’s patients than traditional deep brain stimulation because of the ability to control different cells at specific times.

Gradinaru V, Mogri M, Thompson K, Henderson J, et al. Optical Deconstruction of Parkinsonian Neural Circuitry. Science. 2009; 324(5925): 354-9.


Optical Deconstruction of Parkinsonian Neural Circuitry
Publication Date
Gradinaru V, Mogri M, Thompson K, Henderson J, et al.
Volume & Issue
Volume 324, Issue 5925
Read Full Resource


  • Innovative Medical Research
  • Future Value

Related Facts

  • New Medicines in Development for Parkinson’s Disease in 2018
  • A study of Parkinson’s disease treatments found that pramipexole is a cost-effective treatment for early and advanced Parkinson’s disease. The total cost-effectiveness ratio was $8,837/QALY for patients with early Parkinson’s…  
  • Use of existing or new drugs/compounds for Alzheimer’s prevention could result in a delay of onset of between 2 and 5 years.  
  • Donepezil, a cholinesterase inhibitor, has been found to slow progression of Alzheimer’s disease in its early stages, delaying the need for nursing home care by an average of 30 months.  
  • A current drug in development addresses the underlying cause of type 2 diabetes by modulating genes responsible for insulin sensitization.